Mafenide acetate

🔍1.Product Features
Sulfamonomethoxine acetate is a synthetic topical sulfonamide antibacterial agent with distinct characteristics compared to traditional systemic sulfonamide drugs:

Broad-spectrum antibacterial activity:

It exhibits potent antibacterial activity against both Gram-positive bacteria (e.g., Staphylococcus aureus) and Gram-negative bacteria (e.g., Pseudomonas aeruginosa, Escherichia coli).

It is particularly effective against clinically prevalent Pseudomonas aeruginosa, representing a key advantage for its use in burn treatment.

Unique Mechanism of Action and Resistance to Pus:
Its chemical structure differs significantly from para-aminobenzoic acid (PABA), rendering its antimicrobial activity unaffected by pus, necrotic tissue, or PABA. Unlike many other sulfonamide drugs, this makes it particularly suitable for infected wounds.

Strong Tissue Penetration:

It rapidly penetrates eschar and necrotic tissue, achieving effective antimicrobial concentrations within burn wounds to target deep infections. This represents one of its core advantages as a topical agent.

For Topical Use Only:

Systemic absorption through wounds may cause systemic side effects such as acidosis. Therefore, oral or injectable administration is strictly prohibited. It is intended solely for topical formulations (e.g., creams, solutions).

Weak Antibacterial Inhibitor:

Like most sulfonamides, it acts as a bacteriostatic agent, primarily by interfering with bacterial folate metabolism.

📌2.Primary Applications
The application of sulfamethoxazole is highly focused:

Prevention and Treatment of Burn Wound Infections:

Primary use. Employed on second- and third-degree burn wounds to prevent and control infections caused by susceptible bacteria (particularly Pseudomonas aeruginosa).

Commonly used as prophylactic medication following debridement in the early burn phase, as well as for treating established localized infections.

Other Traumatic and Cutaneous Infections:
Occasionally used for infection prevention in other skin/soft tissue injuries, ulcers, or surgical wounds, though burns remain its classic and primary indication.

Formulation:
Clinically available as 5%-10% sulfamethoxazole acetate ointment or solution, applied directly to debrided wounds.

Important Clinical Considerations:

Due to the potential for metabolic acidosis (resulting from inhibition of carbonic anhydrase), acid-base balance should be monitored during extensive or prolonged use.

Topical application may cause local pain, burning sensation, and allergic reactions.

📦3.Packaging and Storage
As a pharmaceutical active ingredient, its packaging and storage adhere to strict regulations:

Packaging:

Typically packaged in pharmaceutical-grade cardboard drums lined with polyethylene bags or in well-sealed polyethylene drums.

Common specifications include: 1 kg/bag, 5 kg/bag, 10 kg/drum, 25 kg/drum, etc., determined based on supplier and customer requirements.

Packaging must bear clear labels indicating: product name, CAS number, batch number, production date, expiration date, net weight, manufacturer information, and relevant hazard symbols (if applicable).

Storage Conditions:

Store sealed and protected from light. This is critical to prevent moisture absorption and oxidative degradation.

Keep in a cool, dry, well-ventilated warehouse.

The ideal storage temperature is typically 2-8°C (refrigerated) or not exceeding 25°C (cool place), following the recommendations specified in the manufacturer’s Certificate of Analysis (COA). High temperatures and humidity accelerate product degradation.

Must be stored separately from toxic and hazardous substances.

Transportation:

Transport as general chemical/pharmaceutical raw material, protecting against sunlight, rain, and violent impact.

📞Contact information:

Contact: Lucy Yao

Email: lucy@coreychem.com